Appeal No. 1997-2167
Application 08/137,444
is not methylcarbonyl.
Claim 2. The compound of Claim 1 wherein
R is hydrogen, (C -C )alkylcarbonyl or (C -1 1 12 1
C )alkoxycarbonyl;
12
R is (C -C )alkylcarbonyloxy, arylcarbonyloxy,2 1 12
(C -C )alkoxycarbonyloxy, hydroxy, (C -C )1 12 1 6
alkoxycarbonyl(C -C )alkoxy or hydroxy(C -C )1 6 1 6
alkoxy; and
R is hydrogen or halogen; with the proviso that when3
2 1 3 2
R is hydroxy, R and R are not both hydrogen or R
3 1
is hydroxy and R is hydrogen, R is not
methylcarbonyl.
Claim 48. A pharmaceutical composition which
comprises a pharmaceutically acceptable carrier and
an acetylcholinesterase inhibiting amount of the
compound of Claim 1.
Claim 49. A method of treating memory dysfunction
characterized by decreased cholinergic function
which comprises administering to a mammal an
acetylcholine-sterase inhibiting amount of the
compound of Claim 1.
Claim 50. A method of
treating memory dysfunction characterized by
decreased cholinergic function with
6-O-demethylgalanthamine which comprises
administering to a mammal an acetylcholinesterase
inhibiting amount of the compound of Claim 2 when R3
is hydrogen.
RELATED APPEALS
On page 2, lines 1 through 9 of their brief, appellants
direct our attention to two, related appeals which, according
4
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007